PPP2R1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.735000E-01
Normal-vs-Stage2
6.144400E-01
Normal-vs-Stage3
4.915800E-01
Normal-vs-Stage4
5.341400E-01
Stage1-vs-Stage2
8.678600E-01
Stage1-vs-Stage3
8.238000E-01
Stage1-vs-Stage4
8.234800E-01
Stage2-vs-Stage3
8.853000E-01
Stage2-vs-Stage4
8.765600E-01
Stage3-vs-Stage4
9.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.933000E-01
Normal-vs-AfricanAmerican
7.766000E-01
Normal-vs-Asian
1.898570E-01
Caucasian-vs-AfricanAmerican
3.375000E-01
Caucasian-vs-Asian
1.182000E-01
AfricanAmerican-vs-Asian
4.880500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.714200E-01
Normal-vs-Female
8.157800E-01
Male-vs-Female
2.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.533600E-01
Normal-vs-Age(41-60Yrs)
9.525600E-01
Normal-vs-Age(61-80Yrs)
6.184400E-01
Normal-vs-Age(81-100Yrs)
2.317400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.901200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.789000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.397400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.201640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.300400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.167000E-01
Normal-vs-Daily Drinker
3.758800E-01
Normal-vs-Weekly Drinker
2.121600E-01
Normal-vs-Occasional Drinker
9.909200E-01
Normal-vs-Social Drinker
8.353000E-01
Non Drinker-vs-Daily Drinker
6.252200E-01
Non Drinker-vs-Weekly Drinker
3.757600E-01
Non Drinker-vs-Occasional Drinker
2.767200E-01
Non Drinker-vs-Social Drinker
4.258400E-01
Daily Drinker-vs-Weekly Drinker
7.706800E-01
Daily Drinker-vs-Occasional Drinker
1.846210E-01
Daily Drinker-vs-Social Drinker
2.904800E-01
Weekly Drinker-vs-Occasional Drinker
1.362800E-01
Weekly Drinker-vs-Social Drinker
2.132000E-01
Occasional Drinker-vs-Social Drinker
7.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.766000E-02
Normal-vs-Grade 2
1.682360E-02
Normal-vs-Grade 3
6.598200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.920400E-01
Grade 1-vs-Grade 3
9.388200E-01
Grade 1-vs-Grade 4
9.766000E-02
Grade 2-vs-Grade 3
5.683200E-01
Grade 2-vs-Grade 4
1.682360E-02
Grade 3-vs-Grade 4
6.598200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.472800E-01
Normal-vs-NonDiabetic
5.720400E-01
Diabetic-vs-NonDiabetic
5.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.645400E-01
Normal-vs-NoPancreatitis
5.491800E-01
Pancreatitis-vs-NoPancreatitis
9.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.049800E-01
Normal-vs-N1
6.322800E-01
N0-vs-N1
6.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.564300E-02
Normal-vs-TP53-NonMutant
3.212200E-01
TP53-Mutant-vs-TP53-NonMutant
2.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
